Global DTaP and Tdap Vaccines Market Research Report 2020

Published Date : 2020-03-24

Category : Pharma & Healthcare

No. of Pages : 124


The global DTaP and Tdap Vaccines market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
This report focuses on DTaP and Tdap Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall DTaP and Tdap Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the DTaP and Tdap Vaccines market is segmented into
DTaP
Td
Tdap

Segment by Application
Adult
Pediatric

Global DTaP and Tdap Vaccines Market: Regional Analysis
The DTaP and Tdap Vaccines market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the DTaP and Tdap Vaccines market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global DTaP and Tdap Vaccines Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global DTaP and Tdap Vaccines market include:
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc

Table of Contents

1 DTaP and Tdap Vaccines Market Overview
1.1 Product Overview and Scope of DTaP and Tdap Vaccines
1.2 DTaP and Tdap Vaccines Segment by Type
1.2.1 Global DTaP and Tdap Vaccines Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 DTaP
1.2.3 Td
1.2.4 Tdap
1.3 DTaP and Tdap Vaccines Segment by Application
1.3.1 DTaP and Tdap Vaccines Sales Comparison by Application: 2020 VS 2026
1.3.2 Adult
1.3.3 Pediatric
1.4 Global DTaP and Tdap Vaccines Market Size Estimates and Forecasts
1.4.1 Global DTaP and Tdap Vaccines Revenue 2015-2026
1.4.2 Global DTaP and Tdap Vaccines Sales 2015-2026
1.4.3 DTaP and Tdap Vaccines Market Size by Region: 2020 Versus 2026

2 Global DTaP and Tdap Vaccines Market Competition by Manufacturers
2.1 Global DTaP and Tdap Vaccines Sales Market Share by Manufacturers (2015-2020)
2.2 Global DTaP and Tdap Vaccines Revenue Share by Manufacturers (2015-2020)
2.3 Global DTaP and Tdap Vaccines Average Price by Manufacturers (2015-2020)
2.4 Manufacturers DTaP and Tdap Vaccines Manufacturing Sites, Area Served, Product Type
2.5 DTaP and Tdap Vaccines Market Competitive Situation and Trends
2.5.1 DTaP and Tdap Vaccines Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key DTaP and Tdap Vaccines Players (Opinion Leaders)

3 DTaP and Tdap Vaccines Retrospective Market Scenario by Region
3.1 Global DTaP and Tdap Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global DTaP and Tdap Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America DTaP and Tdap Vaccines Market Facts & Figures by Country
3.3.1 North America DTaP and Tdap Vaccines Sales by Country
3.3.2 North America DTaP and Tdap Vaccines Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe DTaP and Tdap Vaccines Market Facts & Figures by Country
3.4.1 Europe DTaP and Tdap Vaccines Sales by Country
3.4.2 Europe DTaP and Tdap Vaccines Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific DTaP and Tdap Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific DTaP and Tdap Vaccines Sales by Region
3.5.2 Asia Pacific DTaP and Tdap Vaccines Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America DTaP and Tdap Vaccines Market Facts & Figures by Country
3.6.1 Latin America DTaP and Tdap Vaccines Sales by Country
3.6.2 Latin America DTaP and Tdap Vaccines Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa DTaP and Tdap Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa DTaP and Tdap Vaccines Sales by Country
3.7.2 Middle East and Africa DTaP and Tdap Vaccines Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global DTaP and Tdap Vaccines Historic Market Analysis by Type
4.1 Global DTaP and Tdap Vaccines Sales Market Share by Type (2015-2020)
4.2 Global DTaP and Tdap Vaccines Revenue Market Share by Type (2015-2020)
4.3 Global DTaP and Tdap Vaccines Price Market Share by Type (2015-2020)
4.4 Global DTaP and Tdap Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global DTaP and Tdap Vaccines Historic Market Analysis by Application
5.1 Global DTaP and Tdap Vaccines Sales Market Share by Application (2015-2020)
5.2 Global DTaP and Tdap Vaccines Revenue Market Share by Application (2015-2020)
5.3 Global DTaP and Tdap Vaccines Price by Application (2015-2020)

6 Company Profiles and Key Figures in DTaP and Tdap Vaccines Business
6.1 Sanofi Pasteur
6.1.1 Corporation Information
6.1.2 Sanofi Pasteur Description, Business Overview and Total Revenue
6.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Sanofi Pasteur Products Offered
6.1.5 Sanofi Pasteur Recent Development
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline DTaP and Tdap Vaccines Production Sites and Area Served
6.2.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.2.4 GlaxoSmithKline Products Offered
6.2.5 GlaxoSmithKline Recent Development
6.3 Protein Sciences Corporation
6.3.1 Protein Sciences Corporation DTaP and Tdap Vaccines Production Sites and Area Served
6.3.2 Protein Sciences Corporation Description, Business Overview and Total Revenue
6.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Protein Sciences Corporation Products Offered
6.3.5 Protein Sciences Corporation Recent Development
6.4 Novartis AG
6.4.1 Novartis AG DTaP and Tdap Vaccines Production Sites and Area Served
6.4.2 Novartis AG Description, Business Overview and Total Revenue
6.4.3 Novartis AG DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Novartis AG Products Offered
6.4.5 Novartis AG Recent Development
6.5 Seqirus
6.5.1 Seqirus DTaP and Tdap Vaccines Production Sites and Area Served
6.5.2 Seqirus Description, Business Overview and Total Revenue
6.5.3 Seqirus DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Seqirus Products Offered
6.5.5 Seqirus Recent Development
6.6 Merck Sharp & Dohme Corp
6.6.1 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Production Sites and Area Served
6.6.2 Merck Sharp & Dohme Corp Description, Business Overview and Total Revenue
6.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Merck Sharp & Dohme Corp Products Offered
6.6.5 Merck Sharp & Dohme Corp Recent Development
6.7 Astellas Pharma US, Inc
6.6.1 Astellas Pharma US, Inc DTaP and Tdap Vaccines Production Sites and Area Served
6.6.2 Astellas Pharma US, Inc Description, Business Overview and Total Revenue
6.6.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Astellas Pharma US, Inc Products Offered
6.7.5 Astellas Pharma US, Inc Recent Development
6.8 Pfizer Inc
6.8.1 Pfizer Inc DTaP and Tdap Vaccines Production Sites and Area Served
6.8.2 Pfizer Inc Description, Business Overview and Total Revenue
6.8.3 Pfizer Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Pfizer Inc Products Offered
6.8.5 Pfizer Inc Recent Development
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson DTaP and Tdap Vaccines Production Sites and Area Served
6.9.2 Johnson & Johnson Description, Business Overview and Total Revenue
6.9.3 Johnson & Johnson DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Johnson & Johnson Products Offered
6.9.5 Johnson & Johnson Recent Development
6.10 Lanzhou Institute of Biological Products Co., Ltd
6.10.1 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Production Sites and Area Served
6.10.2 Lanzhou Institute of Biological Products Co., Ltd Description, Business Overview and Total Revenue
6.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Lanzhou Institute of Biological Products Co., Ltd Products Offered
6.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Development
6.11 AstraZeneca
6.11.1 AstraZeneca DTaP and Tdap Vaccines Production Sites and Area Served
6.11.2 AstraZeneca DTaP and Tdap Vaccines Description, Business Overview and Total Revenue
6.11.3 AstraZeneca DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.11.4 AstraZeneca Products Offered
6.11.5 AstraZeneca Recent Development
6.12 Emergent BioSolutions Inc
6.12.1 Emergent BioSolutions Inc DTaP and Tdap Vaccines Production Sites and Area Served
6.12.2 Emergent BioSolutions Inc DTaP and Tdap Vaccines Description, Business Overview and Total Revenue
6.12.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Emergent BioSolutions Inc Products Offered
6.12.5 Emergent BioSolutions Inc Recent Development

7 DTaP and Tdap Vaccines Manufacturing Cost Analysis
7.1 DTaP and Tdap Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of DTaP and Tdap Vaccines
7.4 DTaP and Tdap Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 DTaP and Tdap Vaccines Distributors List
8.3 DTaP and Tdap Vaccines Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global DTaP and Tdap Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of DTaP and Tdap Vaccines by Type (2021-2026)
10.1.2 Global Forecasted Revenue of DTaP and Tdap Vaccines by Type (2021-2026)
10.2 DTaP and Tdap Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of DTaP and Tdap Vaccines by Application (2021-2026)
10.2.2 Global Forecasted Revenue of DTaP and Tdap Vaccines by Application (2021-2026)
10.3 DTaP and Tdap Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of DTaP and Tdap Vaccines by Region (2021-2026)
10.3.2 Global Forecasted Revenue of DTaP and Tdap Vaccines by Region (2021-2026)
10.4 North America DTaP and Tdap Vaccines Estimates and Projections (2021-2026)
10.5 Europe DTaP and Tdap Vaccines Estimates and Projections (2021-2026)
10.6 Asia Pacific DTaP and Tdap Vaccines Estimates and Projections (2021-2026)
10.7 Latin America DTaP and Tdap Vaccines Estimates and Projections (2021-2026)
10.8 Middle East and Africa DTaP and Tdap Vaccines Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer


List of Tables
Table 1. Global DTaP and Tdap Vaccines Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global DTaP and Tdap Vaccines Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global DTaP and Tdap Vaccines Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key DTaP and Tdap Vaccines Manufacturers Covered in This Study
Table 5. Global DTaP and Tdap Vaccines Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global DTaP and Tdap Vaccines Sales Share by Manufacturers (2015-2020)
Table 7. Global DTaP and Tdap Vaccines Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global DTaP and Tdap Vaccines Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market DTaP and Tdap Vaccines Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers DTaP and Tdap Vaccines Sales Sites and Area Served
Table 11. Manufacturers DTaP and Tdap Vaccines Product Types
Table 12. Global DTaP and Tdap Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global DTaP and Tdap Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DTaP and Tdap Vaccines as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key DTaP and Tdap Vaccines Players
Table 16. Global DTaP and Tdap Vaccines Sales (K Units) by Region (2015-2020)
Table 17. Global DTaP and Tdap Vaccines Sales Market Share by Region (2015-2020)
Table 18. Global DTaP and Tdap Vaccines Revenue (Million US$) by Region (2015-2020)
Table 19. Global DTaP and Tdap Vaccines Revenue Market Share by Region (2015-2020)
Table 20. North America DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units)
Table 21. North America DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020)
Table 22. North America DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 23. North America DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020)
Table 24. Europe DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units)
Table 25. Europe DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020)
Table 26. Europe DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific DTaP and Tdap Vaccines Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific DTaP and Tdap Vaccines Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific DTaP and Tdap Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific DTaP and Tdap Vaccines Revenue Market Share by Region (2015-2020)
Table 32. Latin America DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units)
Table 33. Latin America DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020)
Table 34. Latin America DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020)
Table 40. Global DTaP and Tdap Vaccines Sales (K Units) by Type (2015-2020)
Table 41. Global DTaP and Tdap Vaccines Sales Share by Type (2015-2020)
Table 42. Global DTaP and Tdap Vaccines Revenue (Million US$) by Type (2015-2020)
Table 43. Global DTaP and Tdap Vaccines Revenue Share by Type (2015-2020)
Table 44. Global DTaP and Tdap Vaccines Price (USD/Unit) by Type (2015-2020)
Table 45. Global DTaP and Tdap Vaccines Sales (K Units) by Application (2015-2020)
Table 46. Global DTaP and Tdap Vaccines Sales Market Share by Application (2015-2020)
Table 47. Global DTaP and Tdap Vaccines Sales Growth Rate by Application (2015-2020)
Table 48. Sanofi Pasteur DTaP and Tdap Vaccines Corporation Information
Table 49. Sanofi Pasteur Description and Business Overview
Table 50. Sanofi Pasteur DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Sanofi Pasteur Main Product
Table 52. Sanofi Pasteur Recent Development
Table 53. GlaxoSmithKline DTaP and Tdap Vaccines Corporation Information
Table 54. GlaxoSmithKline Corporation Information
Table 55. GlaxoSmithKline DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. GlaxoSmithKline Main Product
Table 57. GlaxoSmithKline Recent Development
Table 58. Protein Sciences Corporation DTaP and Tdap Vaccines Corporation Information
Table 59. Protein Sciences Corporation Corporation Information
Table 60. Protein Sciences Corporation DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Protein Sciences Corporation Main Product
Table 62. Protein Sciences Corporation Recent Development
Table 63. Novartis AG DTaP and Tdap Vaccines Corporation Information
Table 64. Novartis AG Corporation Information
Table 65. Novartis AG DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Novartis AG Main Product
Table 67. Novartis AG Recent Development
Table 68. Seqirus DTaP and Tdap Vaccines Corporation Information
Table 69. Seqirus Corporation Information
Table 70. Seqirus DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Seqirus Main Product
Table 72. Seqirus Recent Development
Table 73. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Corporation Information
Table 74. Merck Sharp & Dohme Corp Corporation Information
Table 75. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Merck Sharp & Dohme Corp Main Product
Table 77. Merck Sharp & Dohme Corp Recent Development
Table 78. Astellas Pharma US, Inc DTaP and Tdap Vaccines Corporation Information
Table 79. Astellas Pharma US, Inc Corporation Information
Table 80. Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Astellas Pharma US, Inc Main Product
Table 82. Astellas Pharma US, Inc Recent Development
Table 83. Pfizer Inc DTaP and Tdap Vaccines Corporation Information
Table 84. Pfizer Inc Corporation Information
Table 85. Pfizer Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Pfizer Inc Main Product
Table 87. Pfizer Inc Recent Development
Table 88. Johnson & Johnson DTaP and Tdap Vaccines Corporation Information
Table 89. Johnson & Johnson Corporation Information
Table 90. Johnson & Johnson DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Johnson & Johnson Main Product
Table 92. Johnson & Johnson Recent Development
Table 93. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Corporation Information
Table 94. Lanzhou Institute of Biological Products Co., Ltd Corporation Information
Table 95. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Lanzhou Institute of Biological Products Co., Ltd Main Product
Table 97. Lanzhou Institute of Biological Products Co., Ltd Recent Development
Table 98. AstraZeneca DTaP and Tdap Vaccines Corporation Information
Table 99. AstraZeneca Corporation Information
Table 100. AstraZeneca DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. AstraZeneca Main Product
Table 102. AstraZeneca Recent Development
Table 103. Emergent BioSolutions Inc DTaP and Tdap Vaccines Corporation Information
Table 104. Emergent BioSolutions Inc Corporation Information
Table 105. Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Emergent BioSolutions Inc Main Product
Table 107. Emergent BioSolutions Inc Recent Development
Table 108. Sales Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. DTaP and Tdap Vaccines Distributors List
Table 111. DTaP and Tdap Vaccines Customers List
Table 112. Market Key Trends
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Global DTaP and Tdap Vaccines Sales (K Units) Forecast by Type (2021-2026)
Table 116. Global DTaP and Tdap Vaccines Sales Market Share Forecast by Type (2021-2026)
Table 117. Global DTaP and Tdap Vaccines Revenue (Million US$) Forecast by Type (2021-2026)
Table 118. Global DTaP and Tdap Vaccines Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 119. Global DTaP and Tdap Vaccines Sales (K Units) Forecast by Application (2021-2026)
Table 120. Global DTaP and Tdap Vaccines Revenue (Million US$) Forecast by Application (2021-2026)
Table 121. Global DTaP and Tdap Vaccines Sales (K Units) Forecast by Region (2021-2026)
Table 122. Global DTaP and Tdap Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 123. Global DTaP and Tdap Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Global DTaP and Tdap Vaccines Revenue Market Share Forecast by Region (2021-2026)
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of DTaP and Tdap Vaccines
Figure 2. Global DTaP and Tdap Vaccines Sales Market Share by Type: 2020 VS 2026
Figure 3. DTaP Product Picture
Figure 4. Td Product Picture
Figure 5. Tdap Product Picture
Figure 6. Global DTaP and Tdap Vaccines Consumption Market Share by Application: 2020 VS 2026
Figure 7. Adult
Figure 8. Pediatric
Figure 9. Global DTaP and Tdap Vaccines Market Size 2015-2026 (US$ Million)
Figure 10. Global DTaP and Tdap Vaccines Sales Capacity (K Units) (2015-2026)
Figure 11. Global DTaP and Tdap Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 12. DTaP and Tdap Vaccines Sales Share by Manufacturers in 2020
Figure 13. Global DTaP and Tdap Vaccines Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by DTaP and Tdap Vaccines Revenue in 2019
Figure 15. DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global DTaP and Tdap Vaccines Sales Market Share by Region (2015-2020)
Figure 17. Global DTaP and Tdap Vaccines Sales Market Share by Region in 2019
Figure 18. Global DTaP and Tdap Vaccines Revenue Market Share by Region (2015-2020)
Figure 19. Global DTaP and Tdap Vaccines Revenue Market Share by Region in 2019
Figure 20. North America DTaP and Tdap Vaccines Sales Market Share by Country in 2019
Figure 21. North America DTaP and Tdap Vaccines Revenue Market Share by Country in 2019
Figure 22. U.S. DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe DTaP and Tdap Vaccines Sales Market Share by Country in 2019
Figure 27. Europe DTaP and Tdap Vaccines Revenue Market Share by Country in 2019
Figure 28. Germany DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 31. France DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific DTaP and Tdap Vaccines Sales Market Share by Region in 2019
Figure 39. Asia Pacific DTaP and Tdap Vaccines Revenue Market Share by Region in 2019
Figure 40. China DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 41. China DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. India DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America DTaP and Tdap Vaccines Sales Market Share by Country in 2019
Figure 63. Latin America DTaP and Tdap Vaccines Revenue Market Share by Country in 2019
Figure 64. Mexico DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Country in 2019
Figure 71. Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Country in 2019
Figure 72. Turkey DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 77. U.A.E DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of DTaP and Tdap Vaccines by Type (2015-2020)
Figure 79. Sales Market Share of DTaP and Tdap Vaccines by Type in 2019
Figure 80. Revenue Share of DTaP and Tdap Vaccines by Type (2015-2020)
Figure 81. Revenue Market Share of DTaP and Tdap Vaccines by Type in 2019
Figure 82. Global DTaP and Tdap Vaccines Sales Growth by Type (2015-2020) (K Units)
Figure 83. Global DTaP and Tdap Vaccines Sales Market Share by Application (2015-2020)
Figure 84. Global DTaP and Tdap Vaccines Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of DTaP and Tdap Vaccines by Application (2015-2020)
Figure 86. Global Revenue Share of DTaP and Tdap Vaccines by Application in 2020
Figure 87. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Protein Sciences Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Seqirus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Merck Sharp & Dohme Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Astellas Pharma US, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Pfizer Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Lanzhou Institute of Biological Products Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Emergent BioSolutions Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Price Trend of Key Raw Materials
Figure 100. Manufacturing Cost Structure of DTaP and Tdap Vaccines
Figure 101. Manufacturing Process Analysis of DTaP and Tdap Vaccines
Figure 102. DTaP and Tdap Vaccines Industrial Chain Analysis
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Porter's Five Forces Analysis
Figure 106. North America DTaP and Tdap Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. North America DTaP and Tdap Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Europe DTaP and Tdap Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Europe DTaP and Tdap Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America DTaP and Tdap Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America DTaP and Tdap Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa DTaP and Tdap Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa DTaP and Tdap Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific DTaP and Tdap Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific DTaP and Tdap Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed

DTaP and Tdap Vaccines  Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-213-4282

sales@researchreportcenter.com